Skip to content

Direct to Patient Minimal Risk Biospecimen and Data Collection Research

Joined Bio - JB-MR-250225, Direct to Patient Minimal Risk Research

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07128966
Acronym
JBMR
Enrollment
100000
Registered
2025-08-19
Start date
2025-04-01
Completion date
2036-09-01
Last updated
2026-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Celiac, Chronic, Dermatologic, Healthy, Kidney Disease, Lupus

Keywords

biospecimen, rare disease, participant, registry

Brief summary

This study aims to help researchers better understand health conditions and develop improved tests, treatments, and cures for diseases. Joined Bio collects health data, lifestyle information, biological samples, and feedback from participants and provides this to qualified research partners.

Detailed description

Primary: The primary objective of this study is to connect participants with specific health profiles, along with biospecimens and associated de-identified health data, to scientific researchers who are searching for new diagnostics and treatments for a wide array of conditions. This will accelerate medical discovery by connecting medical research with the power of patient participation. Secondary: The secondary objective of this study is to allow participants with specific health profiles, along with their de-identified health data, to help further the cause of medicine generally through interviews, surveys, and other minimal risk research activities desired by life science organizations.

Interventions

OTHERObservation

This is non-interventional, observational only

Sponsors

Joined Bio
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or female, that are adults \[have reached the Age of Majority = aged 18 to 90 in most US states; aged 19-90 in Alabama or Nebraska; aged 21-90 in Mississippi or Puerto Rico\]. * Have reviewed and signed a consent or e-consent form for this study. If a person with diminished decision-making capacity, their Legally Authorized Representative has reviewed and signed the consent for on their behalf. * Be willing to comply with all study procedures and be available for the duration of the study. * Meets requirements of a current request for research participation (e.g. has previous diagnosis of a medical condition of interest or laboratory results within a specific range). * Pregnant women may be enrolled in this study in accordance with 45 CFR Part 46 Subpart B.

Exclusion criteria

* Unable to meet the Inclusion Criteria listed above. * Prisoners or children * Unable to provide the requested biospecimen(s), data or feedback without placing the individual at risk.

Design outcomes

Primary

MeasureTime frameDescription
Observation for biomarker identification10 yearsThere is no defined study outcome. Rather this is an observational study of multiple participant populations that hopes to identify new biomarkers, treatments and/or diagnostic applications.

Countries

United States

Contacts

CONTACTEmily L Hubbard, BS Biology
ehubbard@joined.bio12567970003
CONTACTJill Mullan
jmullan@joined.bio
PRINCIPAL_INVESTIGATORChris Ianelli, MD

Joined Bio

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 6, 2026